These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21871692)

  • 21. [Neuropathologic, immunologic and psychobiological aspects of Alzheimer's dementia].
    Bauer J; Berger M
    Fortschr Neurol Psychiatr; 1993 Jul; 61(7):225-40. PubMed ID: 8365703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A reply to Dr. Bidzan's article "Relationship between the normal aging ad Alzheimer's dementia. Practical implications].
    Krzymiński S
    Psychiatr Pol; 1994; 28(2):221-30. PubMed ID: 8208866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Animal models of degenerative neurological disease.
    Cork LC; Kitt CA; Struble RG; Griffin JW; Price DL
    Prog Clin Biol Res; 1987; 229():241-69. PubMed ID: 3601987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
    Attems J; Jellinger KA
    Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is sporadic Alzheimer's disease a developmental disorder?
    Arendt T; Stieler J; Ueberham U
    J Neurochem; 2017 Nov; 143(4):396-408. PubMed ID: 28397252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NACP/alpha-synuclein, NAC, and beta-amyloid pathology of familial Alzheimer's disease with the E184D presenilin-1 mutation: a clinicopathological study of two autopsy cases.
    Yokota O; Terada S; Ishizu H; Ujike H; Ishihara T; Nakashima H; Yasuda M; Kitamura Y; Uéda K; Checler F; Kuroda S
    Acta Neuropathol; 2002 Dec; 104(6):637-48. PubMed ID: 12410385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Experimental models in Alzheimer's disease].
    Manzano S; González J; Marcos A; Payno M; Villanueva C; Matías-Guiu J
    Neurologia; 2009 May; 24(4):255-62. PubMed ID: 19603296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative neuropathology in aging primates: A perspective.
    Freire-Cobo C; Edler MK; Varghese M; Munger E; Laffey J; Raia S; In SS; Wicinski B; Medalla M; Perez SE; Mufson EJ; Erwin JM; Guevara EE; Sherwood CC; Luebke JI; Lacreuse A; Raghanti MA; Hof PR
    Am J Primatol; 2021 Nov; 83(11):e23299. PubMed ID: 34255875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Speech changes in old age: Methodological considerations for speech-based discrimination of healthy ageing and Alzheimer's disease.
    Ivanova O; Martínez-Nicolás I; Meilán JJG
    Int J Lang Commun Disord; 2024; 59(1):13-37. PubMed ID: 37140204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Animal models of Alzheimer's disease: therapeutic implications.
    Woodruff-Pak DS
    J Alzheimers Dis; 2008 Dec; 15(4):507-21. PubMed ID: 19096153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non human primate models for Alzheimer's disease-related research and drug discovery.
    Van Dam D; De Deyn PP
    Expert Opin Drug Discov; 2017 Feb; 12(2):187-200. PubMed ID: 27960560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amyloid-β targeting immunisation in aged non-human primate (Microcebus murinus).
    Trouche SG; Boutajangout A; Asuni A; Fontés P; Sigurdsson EM; Verdier JM; Mestre-Francés N
    Brain Behav Immun; 2023 Mar; 109():63-77. PubMed ID: 36592872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anti-ageing therapies in Alzheimer's disease].
    Alonso Abreu GS; Brito Armas JM; Castro Fuentes R
    Rev Esp Geriatr Gerontol; 2018; 53(1):45-53. PubMed ID: 28549745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanisms of neuropathological changes in Alzheimer's disease: a review.
    Serý O; Povová J; Míšek I; Pešák L; Janout V
    Folia Neuropathol; 2013; 51(1):1-9. PubMed ID: 23553131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do vervets and macaques respond differently to BMAA?
    Cox PA; Davis DA; Mash DC; Metcalf JS; Banack SA
    Neurotoxicology; 2016 Dec; 57():310-311. PubMed ID: 27133441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aging-related Alzheimer's disease-like neuropathology and functional decline in captive vervet monkeys (Chlorocebus aethiops sabaeus).
    Frye BM; Craft S; Latimer CS; Keene CD; Montine TJ; Register TC; Orr ME; Kavanagh K; Macauley SL; Shively CA
    Am J Primatol; 2021 Nov; 83(11):e23260. PubMed ID: 33818801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain aging, Alzheimer's disease, and the role of stem cells in primate comparative studies.
    August I; Semendeferi K; Marchetto MC
    J Comp Neurol; 2022 Dec; 530(17):2940-2953. PubMed ID: 35929189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strengths and Weaknesses of the Gray Mouse Lemur (
    Pifferi F; Epelbaum J; Aujard F
    Front Pharmacol; 2019; 10():1291. PubMed ID: 31736761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.